Andrew Oxenreiter

Creating Reliable, Secure Processes

Andrew has played critical roles in the administration of many of the largest and most complex settlement programs in history. Combining years of experience attained from working as an attorney and a certified Project Management Professional, he directs teams of attorneys, analysts, project managers and software developers to design and implement creative solutions in mass claim programs and class action settlements.

“​​​​​​​​​​​​​I love the combination of legal analysis and number crunching. More importantly, I feel privileged to help thousands of claimants find equitable relief.”​​​​​​​​​​​​​​

He focuses on creating processes to calculate and execute the payment of claim awards to settlement beneficiaries, all aspects of Qualified Settlement Fund administration, developing systems for evaluating lost income claims in economic loss settlements, and resolving issues related to third-party funder transactions in mass tort settlements. Some of his work has included:

• The $50 billion National Opioid Settlements that resolve all opioid litigation brought by state and local governments against drug distributors, manufacturers, and other entities in the opioid pharmaceutical supply chain In re: National Prescription Opiate Litigation, MDL Docket No. 2804.
• The $6 billion Combat Arms Earplugs Settlement Program that resolves claims from more than 270,000 claimants, arising from In re: Combat Arms Earplug Product Liability Litigation, MDL Docket No. 2885.
• The $14.2 billion Fire Victim Trust, a fund established for the benefit of claimants who suffered property loss, emotional distress and other damages as a result of the Butte, North Bay, and Camp Fires in Northern California.
• The $12 billion Deepwater Horizon Economic and Property Damage Settlement Program arising from In re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, MDL Docket No. 2179, and the Gulf Coast Claims Facility that preceded it.
• The NFL Concussion Settlement Fund arising from In re: National Football League Players’ Concussion Injury Litigation, MDL Docket No. 2323.
• The Xarelto Settlement Program arising from In re: Xarelto® (Rivaroxaban) Products Liability Litigation, MDL Docket No. 2592.